Graham Capital Management, L.P. Seres Therapeutics, Inc. Transaction History

Graham Capital Management, L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$0.75 - $1.56 $111,053 - $230,990	148,071 Added 91.79%	309,379 $238,000
Q4 2023 Feb 14, 2024	SELL	$0.93 - $2.15 $42,342 - $97,889	-45,530 Reduced 22.01%	161,308 $225,000
Q3 2023 Nov 22, 2023	BUY	$2.33 - $5.07 $423,959 - $922,521	181,957 Added 731.31%	206,838 $492,000
Q2 2023 Aug 14, 2023	BUY	$4.67 - $6.55 $116,194 - $162,970	24,881 New	24,881 $119,000
Q3 2022 Nov 14, 2022	SELL	$3.5 - $7.2 $498,396 - $1.03 Million	-142,399 Reduced 57.3%	106,134 $681,000
Q2 2022 Aug 15, 2022	BUY	$2.7 - $7.62 $381,091 - $1.08 Million	141,145 Added 131.43%	248,533 $852,000
Q1 2022 May 16, 2022	SELL	$6.3 - $8.84 $12,763 - $17,909	-2,026 Reduced 1.85%	107,388 $764,000
Q4 2021 Feb 14, 2022	BUY	$6.02 - $11.43 $658,672 - $1.25 Million	109,414 New	109,414 $911,000

46.7M

119K

466K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $102M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Graham Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Graham Capital Management, L.P. with notifications on news.